Kwamitin Ba da Shawarwari na Magungunan Magunguna da Abubuwan Halittu na FDA (VRBPAC) yana riƙe da mahimmanci. taron a ranar 22 ga Mayu, 2025. A karkashin la'akari a wannan taron shi ne makomar Covid booster Shots. An yi jira da yawa da kuma da'awar kafofin watsa labarai cewa shawarwarin da aka ba da izini na yau da kullun don amfani da waɗannan samfuran, musamman a yara da mata masu juna biyu, na iya dainawa.
A halin yanzu ana neman ra'ayoyin jama'a don taron, kuma sha'awar jama'a ta kewaye wannan taron. Abin takaici, na sami rahotanni daga abokan aiki cewa wasu maganganun da aka gabatar wa kwamitin suna kira ga dakatar da waɗannan maganin rigakafi sun ɓace daga gidan yanar gizon FDA.
Har ila yau, mai mahimmanci Labari daga FDA da aka buga yau a cikin New England Journal of Medicine ya yarda da babban bambance-bambance a cikin shawarwarin rigakafin Covid a cikin Amurka da sauran ƙasashe - kamar yadda na bayyana dalla-dalla a ƙasa. Labarin ya sake nuna alamun yiwuwar sauye-sauye a shawarwarin hukuma game da rigakafin Covid. Dangane da ainihin sauye-sauye, duk da haka, har yanzu ba a bayyana ko ɗaya a hukumance ba
Roko na ga kwamitin VRBPAC an buga shi cikin alheri a nan ta Brownstone, duka biyu don hana bacewar sa ba tare da bata lokaci ba, da kuma jaddada mahimmancin batun cutar da ke da alaƙa da maganin alurar riga kafi, waɗanda FDA ba ta magance su ba a cikin labarinta.
Ya ku membobin kwamitin VRPPAC:
Na gode don karantawa da la'akari da wannan wasiƙar.
Ni ƙwararren likita ne na likitancin ciki wanda ke da fiye da ƙarni na kwata a cikin aikin asibiti, da kuma dogon aiki a likitancin ilimi. A tsawon lokacin aikina, na kula da dubun dubatar marasa lafiya kuma na yi alluran rigakafi da yawa. Na kula da ɗaruruwan marasa lafiya a layin gaba a duk faɗin cutar ta COVID. Na rubuta kuma na buga littafi game da COVID. Na cancanci yin magana a kan batun rigakafin COVID.
A cikin ƙwararrun ra'ayi na, da kuma la'akari da ƙwarewata, na yi imani da gaske cewa ya kamata a cire allurar COVID-19 daga amfani, musamman ga yara da mata masu juna biyu.
Akwai dalilai da yawa da ya sa hakan ke buƙatar faruwa. Don cikakken nazari game da illolin da yawa na COVID-19 harbi, na mayar da ku zuwa ga wannan binciken da takwarorinsu suka yi. labarin sake dubawa wanda - daidai, a gani na - yana kira da a kawar da duk samfuran rigakafin COVID-19 daga kasuwa.
Don dalilan wannan wasiƙar, zan mai da hankali kan sauƙaƙan dalilai da yawa waɗanda suka sa, a ƙaƙƙarfan ƙaƙƙarfan, ba dole ba ne a ba wa yara da mata masu juna biyu waɗannan alluran. Zan fara lissafa dalilana, sannan in ƙara dalla-dalla game da kowannensu cikin tsari a ƙasa.
Dalilan hankali da ya sa bai kamata a ba da shawarar rigakafin COVID-19 ga yara ko mata masu juna biyu ba:
- Wasu ƙasashe da yawa ba sa ba da shawara ko sarrafa abubuwan haɓaka COVID ga yara da matasa masu lafiya, kuma ba su yi hakan ba tsawon shekaru. WHO ta amince. Babu wata lahani da ta faru daga manufofin ƙasashen. Amurka na bukatar ta yi koyi.
- Duk da shawarwarin CDC, ɗaukar masu haɓaka COVID ya yi ƙasa sosai a cikin waɗannan rukunin. Jama'ar Amurka sun riga sun san gaskiya.
- Ganin yanayinsa a matsayin ƙananan ƙwayar cuta, mai saurin yaduwa, kuma ƙwayar cuta mai saurin canzawa, kwayar cutar SARS CoV-2 ita ce ɗan takara mara kyau don rigakafin.
- Binciken fa'idar haɗarin game da allurar COVID ba shi da daɗi sosai, musamman ga yara da mata masu juna biyu.
- Akwai kwararan shaidu cewa allurar COVID ba su da lahani ga haihuwa da ciki. Kada a yi amfani da su a cikin mata masu ciki ko kuma suna son yin ciki.
Wasu ƙasashe da yawa ba sa ba da shawara ko sarrafa abubuwan haɓaka COVID ga yara da matasa masu lafiya, kuma ba su yi hakan ba tsawon shekaru. WHO ta amince. Babu wata lahani da ta faru daga waɗannan manufofin. Amurka na bukatar ta yi koyi.
Yawancin ƙasashen waje ba sa ba da shawarar rigakafin COVID-19 ga yara. Wasu ba su yi haka ba fiye da shekaru biyu. Kamar kwanan nan ruwaito ta CNN:
Ba kamar ƙasashe irin su Burtaniya, Kanada da Ostiraliya ba, Amurka ita kaɗai tana ba da shawarar rigakafin Covid-19 na shekara-shekara don ƙanana da yara masu lafiya. Hukumar Lafiya ta Duniya kuma ba ta ba da shawarar allurar rigakafin Covid-19 na shekara-shekara ga ƙoshin lafiya a ƙasa da 65 ko yara masu lafiya.
WHO ba ta ba da shawarar allurar COVID-19 a cikin yara masu lafiya ba sama da shekaru biyu. A cikin Maris na 2023, Ƙungiyar Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararru na WHO (SAGE) kan rigakafi ya bayyana a cikin sanarwar manema labarai:
"Tasirin lafiyar jama'a na yin allurar rigakafin yara da matasa masu lafiya [na COVID] ya yi ƙasa da ƙaƙƙarfan fa'idodin ingantaccen rigakafin gargajiya ga yara - kamar rotavirus, kyanda, da allurar rigakafin pneumococcal."
Ƙasashen da ke bin waɗannan manufofin ba su ga karuwar mutuwar COVID na yara ba ko haɓakar cututtuka sakamakon waɗannan manufofin hankali. Amurka na bukatar ta yi koyi.
Duk da shawarwarin CDC, ɗaukar masu haɓaka COVID ya yi ƙasa sosai. Jama'ar Amurka sun riga sun san gaskiya. CDC da FDA yakamata su bi kwatance.
Ƙididdiga na yawan Amurkawa waɗanda suka sami zagaye na ƙarshe na masu haɓaka COVID sun yi ƙasa sosai, duk da shawarwarin CDC na yanzu cewa suna ci gaba da samun su. Wannan gaskiya ne musamman ga yara.
An kiyasta Kashi 81% na Amurkawa sun sami allurar COVID a tsayin cutar.
Koyaya, ga manya, ɗaukar sabbin abubuwan haɓakawa na COVID ya kasance kiyasta 22.5%. Idan aka kwatanta, an ƙididdige ɗaukar allurar mura a kashi 46.7%.
Ga yara, ɗaukar sabbin abubuwan haɓakawa na COVID an kiyasta kusan kashi 6.7%. Idan aka kwatanta, ɗaukar allurar mura ya kasance 49.2%.
Me yasa aka sami sabani? Ba shi da ma'ana, rashin gaskiya, da cin mutunci ga marasa lafiya don danganta shi da "jinkirin rigakafi" lokacin da kashi 81% suka sami harbin COVID na farko, kuma har yanzu Amurkawa suna karɓar murabba'in mura a ko kusa da matsakaicin tarihi. Dalilin shi ne cewa marasa lafiya sun fahimci daidai cewa masu haɓaka COVID ba su cikin mafi kyawun amfanin su.
Dogara ga hukumomin kiwon lafiyar jama'a da magunguna gabaɗaya suna cikin ƙarancin tarihi. Ci gaba da tura magungunan da ba dole ba kuma masu cutarwa ga jama'a zai kara dagula wannan.
Matsalar ta ta'allaka ne da harbin COVID, kuma tare da hukumomin da suka dage kan tura su. Jama'ar Amurka sun san ba a nuna su ba. CDC da FDA suna buƙatar bin kwatance.
Ganin yanayinsa a matsayin ƙananan ƙwayar cuta, ƙwayar cuta mai saurin canzawa, ƙwayar cuta ta SARS CoV-2 ba ta da kyau sosai don yin rigakafin.
Don kawai yana da kyau a sanya hular kwano lokacin da za ku hau babur, hakan ba yana nufin ya zama dole lokacin da kuke hawa a cikin mota ba.
Wasu ƙwayoyin cuta, ta yanayinsu, ƙwararrun 'yan takara ne don yin rigakafin. Wasu ba.
Smallpox, alal misali, ɗan takara ne mai kyau don maganin rigakafi. Kwayar cutar COVID-19, SARS CoV-2, ba ita ba ce.
Sankarau yana da kisa, tare da rahoton adadin masu mutuwa kusan 1 cikin 3. Alurar riga kafi da aka samar daga wata cuta mai kisa, idan ta yi tasiri, tana hana kamuwa da cuta mai saurin kisa, wanda ke sa haɗarin shan ta ya fi dacewa. A wasu kalmomi, nazarin haɗarin-amfani na kowane magani na likita ya fi dacewa da kyau idan cutar da ta hana ko magance ta tana da kisa.
Kananan yara kuma suna canzawa a hankali. Don haka, ingantaccen rigakafin da aka samar ko da shekaru da suka gabata yana yiwuwa ya ci gaba da yin tasiri, kuma martanin rigakafin da yake haifarwa yana iya kasancewa mai tasiri cikin lokaci.
Sabanin haka, SARS CoV-2 babban ɗan takarar kamuwa da cuta ne don maganin rigakafi, musamman a cikin yara da mata masu juna biyu.
COVID da wuya ya taɓa kashe yara, ko ma yana sa su rashin lafiya. Ko da a lokacin bala'in cutar, labari a cikin babbar jarida Nature ya kwatanta mutuwar COVID na yara a matsayin "mafi wuyar gaske." Babban tushen yawan jama'a Nazarin Koriya daga 2023 an sami adadin mace-mace a cikin yara daga COVID na 0.85 kawai a cikin shari'o'i 100,000.
Don rashin lafiya da ke da kusan mace-mace - kamar COVID a cikin yara - kawai maganin rigakafi ne mai aminci zai cancanci ko da la'akari. Koyaya, a haƙiƙanin rigakafin COVID suna da guba sosai ga yara.
SARS Cov-2 shima yana canzawa cikin sauri. Don haka, maganin da aka yi shekara ɗaya ko ma watanni da yawa a gaba, yana iya zama mara amfani a lokacin da aka yi shi. Wannan (kazalika da manufar riba) shine dalilin da ya sa ake ba da shawarar sake ƙarfafawa. Kowane mai haɓakawa na gaba yana haɓaka ƙima na guba, yayin da neman rigakafin banza zuwa ƙwayar cuta mai saurin canzawa ta ci gaba har abada.
Kwayoyin cututtuka na numfashi gabaɗaya matalauta ne masu neman allurar rigakafi. SARS CoV-2 misali ne na wannan. Ganin cewa babu makawa, ci gaba, saurin maye gurbi zuwa ƙananan ƙwayoyin cuta, yuwuwar fa'idodin rigakafin maimaitawa yana raguwa kowace rana, yayin da rashin amfani da guba na ci gaba.
A cikin sharuddan ilimin halitta, hatta kwayar cutar SARS CoV-2 ta san maganin COVID ba shi da amfani. CDC da FDA yakamata su bi kwatance.
Binciken haɗarin-amfani na rigakafin COVID ba shi da daɗi sosai, musamman ga yara da mata masu juna biyu.
Babu mai hankali da zai karɓi maganin da zai iya kashe su, don kawai ya hana su kamuwa da mura.
Duk wani maganin rigakafin cutar da ke da kusan mutuwa dole ne ya kasance cikin aminci sosai don dacewa da amfani - musamman tare da yara, waɗanda kamar yadda muka gani, kusan ba su taɓa mutuwa daga kamuwa da cutar COVID ba. Koyaya, rigakafin COVID - musamman nau'ikan tushen mRNA daga Pfizer da Moderna - suna da guba sosai kuma galibi suna mutuwa, gami da yara.
A duk lokacin da aka fara fitar da allurar rigakafin COVID-19 kuma ana ci gaba har zuwa yanzu, jama'a sun kasance masu ba da tabbacin cewa allurar COVID suna "lafiya da inganci." Maimaita ba tare da shaida ba, wannan mantra ya zama ƙarya.
A watan Agusta 2022, bayanan Pfizer na ciki sun bayyana 1.6 miliyan m events daga samfuran su na COVID mRNA, yawancinsu masu mutuwa ne, waɗanda suka haɗa da jijiyoyin jini, neurologic, jijiyoyin jini, da tsarin haihuwa, da sauransu. Lafiya da tasiri?
Zuwa Yuni 2023, da Johnson & Johnson An ciro maganin COVID daga kasuwa - saboda ya kashe mutane. A watan Mayu 2024, da An ja AstraZeneca jab kuma - bayan fiye da allurai biliyan 3 an gudanar da su a duniya. Lafiya da tasiri?
A watan Mayu 2024, Tsarin Ba da Rahoto na Cutar Cutar Cutar Cutar (VAERS) na CDC. kataloji sama da mutane 38,000 da suka mutu sanadiyar allurar COVID-1.5 da fiye da miliyan XNUMX munanan munanan halayen da ke da alaƙa da rigakafin a cikin Amurka. Misalin tsarin Eudravigilance na Turai ya buga irin wannan binciken mai ban tsoro. Lafiya da tasiri?
Zuwa Afrilu 2025, VAERS ta ba da rahoton sama da 96,000 na nakasa ta dindindin da sama da 49,000 mutuwar. Lafiya da tasiri?
Ciwon ciki shine watakila sanannen kuma mafi yawan yarda da mummunan guba wanda harbin COVID mRNA ke haifarwa. Abin takaici yana da yawa a cikin samari da samari. Yana da ba rare, kuma shi ne ba m, kamar yadda aka yi da'awar ƙarya a farkon lokacin fitar da allurar.
Yawancin karatu sun nuna yawan abin da ya faru na myocarditis bayan rigakafin COVID mRNA a cikin samari maza daga 6 zuwa 37 ƙarin lokuta a cikin 100,000 da aka yi wa alurar riga kafi. A cikin ƙasa mai girman Amurka, wannan ya zama annoba da za a iya kaucewa gaba ɗaya ta hanyar rigakafin cututtukan cututtukan zuciya a cikin samari waɗanda adadinsu ya kai dubun dubbai. Kuma myocarditis yana kashe.
A cikin shekaru arba'in kafin bullar rigakafin mRNA COVID a cikin 2021, a matsakaita kusan fitattun 'yan wasan Turai 29 ne ke mutuwa kowace shekara a filin wasa sakamakon kama zuciya. Tun lokacin da allurar COVID suka isa, adadin ya samu ya karu sau goma zuwa 283 a kowace shekara. Adadin matasan da suka mutu a cikin barcinsu sakamakon mutuwar zuciya ta kwatsam ba a cikin wadannan adadin, kuma ya zarce haka.
Kuma myocarditis ne kawai daya daga cikin abubuwan da za a iya kashe su da waɗannan alluran. Maimaita wannan ƙima sau da yawa da yawa - don cututtukan jini, cututtukan rigakafi, malignancies, da sauransu.
Hauka ne a zahiri yin da'awar "kare" marasa lafiya da irin wannan magani mai guba, daga cutar da ke haifar da barazanar mutuwa.
Akwai kwararan shaidu cewa allurar COVID na yin illa ga haihuwa da ciki. Kada a yi amfani da su a cikin mata masu ciki ko kuma suna son yin ciki.
Ɗaya daga cikin ka'idodin ka'idodin maganin Maternal-Fetal shine cewa, kamar yadda zai yiwu a duk lokacin ciki, mutum ya kamata bar uwa da yaro mai tasowa su kadai. A mafi yawan lokuta, mahaifiyar tana ba da duk abin da yaron yake bukata don girma da girma. Tashi mai tasowa da sauri yana da saurin kamuwa da guba da raunuka, musamman daga magunguna da sauran hanyoyin kwantar da hankali.
Shekaru da yawa, magunguna an ɗora su a hankali dangane da sanannun, da ake zargi, ko rashin sani mai guba ga tayin mai tasowa, kuma kaɗan ne kawai aka karɓa don amfani akai-akai ga mata masu juna biyu. Bambance-bambance daga wannan hanyar na iya ƙare cikin bala'i, kamar yadda aka nuna a yanayin thalidomide.
Ana sake keta wannan mahimmanci, ka'idar ma'anar magani ta hanyar ba da rigakafin COVID ga mata masu juna biyu.
A shafi na 12 na binciken bayan kasuwa na Pfizer na samfurin COVID-19 mRNA, wanda Pfizer da FDA suka yi ƙoƙarin ɓoye tsawon shekaru 75, binciken game da masu juna biyu da aka yi musu allurar game da masu ciki sun hada da:
Yawan zubewar kashi 81%
Sau biyar na karuwa a cikin haihuwa
Yawan mutuwar jarirai sau takwas
Kashi 14% na matsalolin shayarwa
Yawan jama'a na baya-bayan nan binciken a Jamhuriyar Czech ya nuna cewa jimlar yawan haihuwa a Jamhuriyar Czech ya ragu daga haihuwa 1.83 a cikin mata 1,000 a cikin 2021, zuwa 1.62 a 2022, da 1.45 a 2023. An fitar da allurar rigakafin COVID, ba shakka, an fitar da su a farkon 2021. Bugu da ƙari, binciken ya nuna cewa an sami nasarar yin amfani da allurar rigakafi a cikin kashi 33 cikin XNUMX a cikin XNUMX% a cikin XNUMX. mata marasa alurar riga kafi.
Waɗannan misalan guda 2 ne kawai na manyan shaidun da ke ci gaba da ƙaruwa cewa allurar COVID-19 mRNA sun yi illa ga lafiyar tayin da haihuwa. Dole ne a cire su nan da nan daga amfani da mata masu ciki.
Kamar yadda aka ambata a baya, abin kunya ne na ɗabi'a na rabon tarihi cewa waɗannan harbe-harbe sun kasance abada shawarar yin amfani da yara da mata masu juna biyu. Wannan mummunan kuskuren ya yi tsayi da yawa kuma dole ne a gyara shi nan da nan.
Bayan yara da mata masu juna biyu, akwai dalilai da yawa da yakamata a cire rigakafin COVID-19 daga kasuwa gaba ɗaya. Wataƙila mafi muni shine samfuran COVID mRNA sun lalata su tare da mai guba da yuwuwar cutar plasmid DNA. Dangane da wannan zina kaɗai, yakamata FDA ta fitar da su daga kasuwa, kamar yadda aka tilasta ta yi da duk samfuran da aka lalata a ƙarƙashin tsarinta.
Aƙalla, lokaci ya wuce don ɗiban ƴaƴan ƴaƴan rataye. Da fatan za a yi wannan aiki na bayyane, daidai, kuma wanda ya daɗe. Dama mummunan kuskure. Cire rigakafin COVID daga amfani da yara da mata masu juna biyu.
-
CJ Baker, MD, 2025 Brownstone Fellow, likita ne na likitancin ciki tare da karni na kwata a aikin asibiti. Ya gudanar da alƙawura na likita da yawa, kuma aikinsa ya bayyana a cikin mujallu da yawa, ciki har da Journal of the American Medical Association da New England Journal of Medicine. Daga 2012 zuwa 2018 ya kasance Mataimakin Farfesa na Clinical Associate of Medical Humanities da Bioethics a Jami'ar Rochester.
Duba dukkan posts
